Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dimpal N, Thakkar"'
Autor:
Sandhiya Selvarajan, Biswajit Dubashi, Indumathi Prapath, Dimpal N Thakkar, Subathra Adithan, Kesavan Ramasamy
Publikováno v:
Personalized Medicine. 17:203-212
Aim: Pulmonary toxicity is a well-known adverse reaction of bleomycin. In this study, we investigated the influence of XPC, PMAIP1/Noxa and TLR4 genetic variants on the development of bleomycin-induced lung injury (BILI) in south Indian patients with
Publikováno v:
Journal of cancer research and therapeutics. 17(2)
Aim Bleomycin, etoposide, and cisplatin (BEP) regimen is the standard treatment for germ-cell tumors (GCTs). Bleomycin-induced pulmonary toxicity (BPT) is fatal and dose-limiting toxicity associated with this regimen. In this study, we aimed to ident
Autor:
Sunitha Kodidela, Patchava Dorababu, Dimpal N Thakkar, Biswajit Dubashi, Rajan Sundaram, Niveditha Muralidharan, Ravi Prasad Nidanapu, Anil Aribandi, Suresh Chandra Pradhan, Chakradhara Rao Satyanarayana Uppugunduri
Publikováno v:
Genes, Vol 11, Iss 594, p 594 (2020)
Genetic variants influencing the pharmacokinetics and/or pharmacodynamics of the chemotherapeutic drugs used in Acute Lymphoblastic Leukemia (ALL) therapy often contribute to the occurrence of treatment related toxicity (TRT). In this study, we explo
Autor:
Dimpal N, Thakkar, Indumathi, Prapath, Subathra, Adithan, Kesavan, Ramasamy, Sandhiya, Selvarajan, Biswajit, Dubashi
Publikováno v:
Personalized medicine. 17(3)
Autor:
Sunitha, Kodidela, Patchava, Dorababu, Dimpal N, Thakkar, Biswajit, Dubashi, Rajan, Sundaram, Niveditha, Muralidharan, Ravi Prasad, Nidanapu, Anil, Aribandi, Suresh Chandra, Pradhan, Chakradhara Rao Satyanarayana, Uppugunduri
Publikováno v:
Genes
Genetic variants influencing the pharmacokinetics and/or pharmacodynamics of the chemotherapeutic drugs used in Acute Lymphoblastic Leukemia (ALL) therapy often contribute to the occurrence of treatment related toxicity (TRT). In this study, we explo
Publikováno v:
The International Journal of Biological Markers. 33:514-519
Background: Hodgkin lymphoma, a highly curable malignancy is currently treated with an adriamycin, bleomycin (BLM), vinblastine, and dacarbazine (ABVD) regimen. BLM-induced pulmonary toxicity (BPT) is one of the dose-limiting toxicities. Previous rep
Purpose: To determine the frequency of HLA B*15:02 variant allele in a healthy South Indian population and compare it with other population frequencies. Methods: Five millilitres of venous blood samples were collected from 203 unrelated healthy volun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::b8e02dea516b6d49541163152c93c0de
https://zenodo.org/record/3333671
https://zenodo.org/record/3333671
Autor:
Dimpal N Thakkar, Chakradhara Rao S. Uppugunduri, Rajan Sundaram, Suresh Chandra Pradhan, Sunitha Kodidela, Biswajit Dubashi, Patchava Dorababu, Niveditha Muralidharan, Ravi Prasad Nidanapu, Anil Aribandi
Publikováno v:
Genes. 11:594
Genetic variants influencing the pharmacokinetics and/or pharmacodynamics of the chemotherapeutic drugs used in Acute Lymphoblastic Leukemia (ALL) therapy often contribute to the occurrence of treatment related toxicity (TRT). In this study, we explo